AGN Financial Facts
Total non-operating income (expense): 26.6MBasic (in dollars per share): 1.05
See Full Income Statement
Inventories: 296M
Accrued compensation: 292.8M
See Full Balance Sheet
Allergan Inc. (AGN) Earnings
|
Expand Research on AGN
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +5.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -2.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2/10/20 | Q419 | $5.22 | $4.57 | +$0.65 | $4.35B | $4.09B | N/A |  | | Details | |
11/5/19  |
Q319 | $4.25 | $4.22 | +$0.03 | $4.05M | $3.88M |  |
| | Details | |
| 8/6/19 |  |
Q219 | $4.38 | $4.35 | +$0.03 | $4.09B | $3.94B | |
| | Details |
| 5/7/19 | |
Q119 | $3.79 | $3.55 | +$0.24 | $3.6B | $3.54B | |
| | Details |
| 1/29/19 | |
Q418 | $4.29 | $4.15 | +$0.14 | $4.08B | $4B | |
| | Details |
| 10/30/18 | |
Q318 | $4.15 | $3.97 | +$0.18 | $4.03B | $3.82B | = | | | Details |
| 7/26/18 | |
Q218 | $4.42 | $4.13 | +$0.29 | $4.1B | $3.92B | = | | | Details |
| 4/30/18 | |
Q118 | $3.74 | $3.35 | +$0.39 | $3.67B | $3.59B | = | | | Details |
